top of page

Conclusions & Recommendations

18.6.1 - Chad

Conclusion/Recommendation:

TEC encourages the Ministry of Health to submit a mid-year request for Zithromax® in Bol and Ngouri in Lac if they warrant treatment following their upcoming population-based prevalence surveys.

Action:

The recommendation has been shared with the National Program.

TEC 18

2018

Africa - West

Chad

18.7.1 - Guinea

Conclusion/Recommendation:

Because of a recent publication which indicates an EU prevalence of TF1-9 41.1% for all 5 request districts, Faranah in Faranah does not warrant a 7th round of MDA and should instead conduct a population-based prevalence impact survey in 2019 along with Dabola and Kissidigou in Faranah and Kouroussa in Kankan. Only Dinguiraye in Faranah warrants treatment (round 5 of 5) in 2019, pending confirmation of funding.

Action:

The recommendation has been shared with the National Program.

TEC 18

2018

Africa - West

Guinea

Zithromax® donation criteria

18.8.1 - Mauritania

Conclusion/Recommendation:

TEC recommends to ITI management to provide technical assistance for guidance on the last stages of program implementation, specifically in Nema and Timbedra in Hodh Ech Chargui, which had baseline TF1-9 5-9% in 2004, but no interventions or further surveys.

Action:

ITI is discussing with partners how best to support the National Program in identifying funding for the remaining surveys and providing technical support for dossier preparation, transition strategies, and post-elimination surveillance.

TEC 18

2018

Africa - West

Mauritania

end game, recommendations for ITI management

18.9.1 - Niger

Conclusion/Recommendation:

TEC recommends to the Ministry that:
– they consider conducting MDA coverage surveys in Maine Soroa (in Diffa), Tessaoua (in Maradi), and Miriah (in Zinder);
– they do not delay in-country transport of Zithromax® awaiting the arrival of other NTD drugs, which often delays implementation. The National Program should budget for separate transport for each NTD drug, but if the possibility for integration presents itself, then they should proceed accordingly;
– in accordance with WHO guidelines, districts with populations greater than 250,000 should be split into multiple evaluation units for surveys with boundaries that represent discrete implementation units.

Action:

ITI Supply Chain has worked intensively with partners and the Ministry of Health to improve supply chain management in Niger. This has resulted in the MOH appointing a supply chain manager and providing role clarity in drug management. Further details will be provided in a TEC 19 presentation.

TEC 18

2018

Africa - West

Niger

surveys, supply chain, coverage, evaluation units

17.1.1 - General Recommendations to ITI

Conclusion/Recommendation:

TEC suggests we include a note of praise at the beginning of every country-specific recommendation arising from TEC meetings, where appropriate.

Action:

Done

TEC 17

2017

TEC meeting management

17.1.2 - General Recommendations to ITI

Conclusion/Recommendation:

If future Zithromax® management anomalies arise, ITI should ensure that the relevant donors are also alerted, in addition to the direct implementing partner.

Action:

Implemented

TEC 17

2017

recommendations for ITI management

17.1.3 - General Recommendations to ITI

Conclusion/Recommendation:

TEC requests that ITI Supply Chain develop an overall supply chain strengthening plan and present this at TEC 18.

Action:

Preliminary plan to be presented at TEC 18

TEC 17

2017

supply chain, TEC meeting management

17.1.4 - General Recommendations to ITI

Conclusion/Recommendation:

TEC requests to ITI Management to create a table similar to the WHO global status table including only the antibiotic component rather than full SAFE.

Action:

Included in the TEC 18 Director’s Update

TEC 17

2017

recommendations for ITI management, TEC meeting management

17.1.5 - General Recommendations to ITI

Conclusion/Recommendation:

TEC requests to ITI Management to include the corresponding population figures on the flow chart of districts through program years.

Action:

For program year 2017, there is still outstanding data for Niger, Nigeria, and Kenya. The updated flow chart will be presented at TEC 19

TEC 17

2017

recommendations for ITI management

17.1.6 - General Recommendations to ITI

Conclusion/Recommendation:

At each TEC, include for each country which districts require surveys during the current year and the status of those surveys.

Action:

An overview is included under the TEC 18 Data tab and in each country application

TEC 17

2017

surveys, TEC meeting management

International Trachoma Initiative

330 West Ponce de Leon Avenue

Decatur, GA 30030 

Phone:

+1 800 765 7173
+1 404 371 0466
Fax:

+1 404 371 1087

  • Instagram
  • Facebook
  • Twitter
  • YouTube
bottom of page